poisar

Stocks · News reference

Canaccord Genuity Maintains Hold on Illumina, Raises Price Target to $205

BenzingaAug 3, 2026, 9:21 PMBenzinga Newsdesk

Canaccord Genuity analyst Kyle Mikson maintains Illumina (NASDAQ:ILMN) with a Hold and raises the price target from $190 to $205.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 3, 2026, 9:21 PM
Checked
Aug 3, 2026, 9:21 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncAug 7, 2026, 9:56 AMResearchandmarkets.Com

    Precision Medicine Collaboration and Licensing Deals 2019-2026 | Gain Access to Over 1,350 Deals and Benchmark with Confidence

    ResearchAndMarkets.com released a comprehensive report analyzing 1,350+ precision medicine collaboration and licensing deals from 2019-2026. The report provides detailed benchmarking data on deal structures, financial terms, and contract provisions to support business development and strategy decisions in the precision medicine sector.

    Read original at globenewswire-inc